Literature DB >> 23907378

Effect of infusion rate on intravenous nicotine self-administration in rats.

Victoria C Wing1, Mohammed Shoaib.   

Abstract

The reinforcing effects of addictive drugs are thought to be more robust when the onset of the drug's effects is fast. It is unclear whether this concept extends to intravenous self-administration (IVSA) of nicotine. We therefore sought to examine the effects of infusion duration on nicotine IVSA in rats. Male Lister hooded rats (n=8) were given daily 1 h limited access to fixed ratio-3 nicotine IVSA (0.03 mg/kg/infusion). Once nicotine IVSA was established, the effect of infusion duration on nicotine seeking was evaluated at a constant unit dose and volume (0.5, 5.0, and 19.6 s compared with the 1-s training infusion duration). Active responses were significantly reduced when the infusion duration was increased (i.e. 5 or 19.6 s compared with 0.5 and 1 s), and the effect was qualitatively similar to saline substitution. The likelihood of maintaining a reliable IVSA in rats was reduced by increasing the infusion duration. The infusion duration therefore represents an important determinant of nicotine reinforcement in rats.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23907378     DOI: 10.1097/FBP.0b013e3283644d58

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  13 in total

1.  Nicotine reinforcement in never-smokers.

Authors:  Angela N Duke; Matthew W Johnson; Chad J Reissig; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2015-09-08       Impact factor: 4.530

Review 2.  Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.

Authors:  Jack E Henningfield; Tracy T Smith; Bethea A Kleykamp; Reginald V Fant; Eric C Donny
Journal:  Psychopharmacology (Berl)       Date:  2016-10-21       Impact factor: 4.530

Review 3.  Behavioral mechanisms underlying nicotine reinforcement.

Authors:  Laura E Rupprecht; Tracy T Smith; Rachel L Schassburger; Deanne M Buffalari; Alan F Sved; Eric C Donny
Journal:  Curr Top Behav Neurosci       Date:  2015

4.  Differential effects of nicotine delivery rate on subjective drug effects, urges to smoke, heart rate and blood pressure in tobacco smokers.

Authors:  Kevin P Jensen; Gerald Valentine; Ralitza Gueorguieva; Mehmet Sofuoglu
Journal:  Psychopharmacology (Berl)       Date:  2020-01-29       Impact factor: 4.530

5.  Impact of delivery rate on the acute response to intravenous nicotine: A human laboratory study with implications for regulatory science.

Authors:  Joao P De Aquino; R Ross MacLean; Ralitza Gueorguieva; Elise E DeVito; Tore Eid; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2022-03       Impact factor: 4.280

6.  Sex and heredity are determinants of drug intake in a novel model of rat oral oxycodone self-administration.

Authors:  Burt M Sharp; Xinyu Fan; Eva E Redei; Megan K Mulligan; Hao Chen
Journal:  Genes Brain Behav       Date:  2021-09-16       Impact factor: 3.449

7.  Characterizing the relationship between increases in the cost of nicotine and decreases in nicotine content in adult male rats: implications for tobacco regulation.

Authors:  Tracy T Smith; Laura E Rupprecht; Alan F Sved; Eric C Donny
Journal:  Psychopharmacology (Berl)       Date:  2016-09-14       Impact factor: 4.530

Review 8.  More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder.

Authors:  M J Moerke; L R McMahon; J L Wilkerson
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

9.  Rapid Brain Nicotine Uptake from Electronic Cigarettes.

Authors:  Kiran Kumar Solingapuram Sai; Yantao Zuo; Jed E Rose; Pradeep K Garg; Sudha Garg; Rachid Nazih; Akiva Mintz; Alexey G Mukhin
Journal:  J Nucl Med       Date:  2019-11-01       Impact factor: 10.057

10.  Reinforcing effectiveness of nicotine in nonhuman primates: effects of nicotine dose and history of nicotine self-administration.

Authors:  Stephen J Kohut; Jack Bergman
Journal:  Psychopharmacology (Berl)       Date:  2016-04-14       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.